Bill 111 (Legislature 15, Session 1)

L15 S1 1690

Alberta — Bills

No. 111 1st Session, 15th Legislature, A1berta 12 Elizabeth II BILL 111 A Bill to amend The Alberta PharmaceuticaJ Association Act HON. DR. Ross Printed by L. S. WALL, Printer to the Queen's Most Exce~lent Majesty, Edmonton, Alberta, 1964

Explanatory Notel I. This Bill amends The Alberta Pharmaceutical Association Act which is

chapter 232 of the Revised- Statutes. 2. (

a) Definition of "drug store" etc., amended to include all pharmaceutical services offered to the public by modern day pharmacies. (

b) Reference is changed to

Schedule A. See clause 23 of this Bill. (c) "Prescription" is redefined to include directions given by a podiatrist pursuant to The Podiatry Act. 3. (

a) This amendment will increase the minimum size of council from 7 to 10 members. (b) Subsection (4) presently reads: "

(4) The term of ofHce M a counci:llor i,s two years, but the office of oouncillor shall be vacated if the councillor (

a) by notice in w:r.iting to the president or registrar o·f the AssocI a tion res,igns his office, (

b) Repeailed. 1957, c. 65, s. 3. (

c) ceases to be actively engaged in practislng hils profession of pharmacy, (

d) ceases to be a member of the Association, or (

e) dies, or is found to be a lunatic or becomes of unsound mind.".

BILL No. 111 of 1964

An Act to amend The Alberta Pharmaceutical Association Act (Assented to , 1964) HER MAJESTY, by and with the advice and consent of the Legislative Assembly of the Province of Al:berta, enacts as follows: 1. The Alberta Pharmaceutical Association Act is hereby amended.

Section 2 is amended (

a) by striking out clause (

d) and by substituting the following: (d) "drug store" or "pharmacy" or "dispensary" means a place where prescriptions, drugs, chemicals and poisons are . (

i) sold by retail, or (ii) . compounded, 'Or (iii) dispensed, 'Or (iv) supplied or distributed; (

b) as to clause (h), subclause (ii) by striking out the words "Schedule I" and by substituting the words "Schedule A", (

c) by striking 'Out clause (

i) and by substituting the following: (i) "prescription" means a direction given by a duly qualified medical practitioner, a dentist, veterinary surgeQn or a PQdiatrist for a remedy for a disease or disorder and prescribing the ingredients of the remedy, whether or not the method of use is prescribed; 3. SectiQn 5 is amended (

a) as to subsection (2) by striking out the wQrd "seven" and by substituting the word "ten", (

b) as too subsection (4) (

i) by adding the following clause after clause (a) : (

b) has been reprimanded, fined, suspended 'Or erased from the register pursuant to this Act,

(

c) The purpose of this amendment is to eliminate residence in a district as a qualification for election to the office of councillor. Subsection (8) presently reads: "

(8) No person is eligdble to be elected a councillor unless he is a pharmaceutical chemist residing and actively engaged in practi.ce as a pharmaceUJtical chemist in the district of the Provlince in which he seeks election.", 4. The reference is changed to

Schedule C. 5. The reference is changed to

Schedule C. 6. New.

Section 14 presently reads: "14. The regU,strar of the .Association (ra) Shall open the ballot pa,pers in the presence of at least two other members of tihe AssociatiOon rut the hour of nine o'clock in the evening of the day of election, and (

b) shall scrutinize rand count the votes in the presence of such other members and keep a record thereOof.", 7. The purpose of the amendment is to make provision for some other person to handle the duties of registrar at an election of members of council in the event of his inability to act for the reasons stated. 8. The powers of the Association with respect to what it may do by by-law are more fully set out.

Section 20 presently reads: 2 "20.

(1) Tl}e council (

a) has power to fix suCih fees and make such by-.law·s, rules and regulations not inconsistent with this Act as irt: cOonSiders neces sary for the carrying out of the objects of the A'ssooiwtion. and (

b) in pat'lticu~ar by such by-laws, in addition tOo any OIther powers .it might have, may (

i) fix the exam[nation fee, registrati-on fee, annual fee or other fees to be paid by internes or members of the Association, (id) provide tlJ,atthe annual fee of any member that remains uDoprui,d fOor a period tOo be specified in such by-laws be Oon the expiratiOon of such perdod increased to an amOount <specified in such by-laws, (iii) poovMe that tihe annual fees of nOon-resident Oor nOon-prac tising membe.rs be on a dJifferent basis from those of actJive members, (iv) prOovide fOor the depositing and disbursement Oof the funds of ,the AssociatiOon, (

v) provide that each active member be suwlied Wlith and keep prominently dlisplayed in his place of business ra certificate showing t1)rut he is a member Oof the .AssocdatiOon, (vii) provide (

A) fOor the st'riking Ooff the register and suspension from practice as a member Oof the AssociatiOon of any member fOor non-payment of fees due tOo the AssociatliOn, and (

B) for the reinstatement of such member upon suoh tenns as the council decides, and (vii) from time to time amend or revoke any such by-laws Oor substitute other by-laws in the,ir stead.

(2) Suoh by-laws, rules and regula;tions may also be amended, altered or repe8iled in whole or in pa.rt rut any annual geneml meeting of the Associa;mon, if nOotice is given Oof the inteIlition to do so .In accordance with theby-laWlS in force fOorthe time bedng.".

(ii) by adding after the words "ceases to be" in clause (

c) the words ", a resident of the Prov ince or", (

c) as to subsection (8) by striking out the words "residing and".

Section 12 is amended by striking out the words "Schedule II" and by substituting the words "Schedule C".

Section 13, subsection (1) is, amended by striking out the words "Schedule II" and by substituting the words "Schedule C".

Section 14 is amended by adding the word ", and" at the end of clause (

b) and by adding the following clause after clause ( b) : (

c) shall keep the ballot p'apers for a period of one month and shall then destroy them. 7. The following

section is added after

section 17: 17a. If there is no registrar at the time at which an election is to be held or if the registrar is unable from ill ness or other unavoida;ble cause to act at the election, the president shall appoint under his hand some other person to act as registrar, and the person so appointed shall per form all the duties of the registrar as prescribed by this Act.

Section 20 is struck out and the following is substi tuted: 20.

(1) The council may fix such fees and make such by-laws, rules and regulations not inconsistent with this Act as it considers necessary for the c'arrying out of the objects of the Association and without restricting the gen erality of the foregoing, may 2 (

a) fix the examination fee, registration fee, annual fees or other fees to be paid by pharmaceutical internes or members of the Association, (

b) provide for the regulation of the meetings and proceedings of the Association and the council, (

c) provide for the appointment and remuneration of teachers, examiners, inspectors and such other per sons as the council may employ and prescribing their duties, (

d) provide for the renumeration and expenses of mem Ibers of the council or of persons employed by the council in attending its sittings or engaging upon the business of the council, (

e) provide for the depositing and disbursement of the funds of the Association,

9. The discipline provisions of the Act are revised and extended to ,bring them into line with the disciplining powers and procedures found in the Acts governing other professional organizations.

Section 21 presently reads: "21.

(1) The council may by resolution declare that any person tis, in the opindon of the council, unfM to be a member Qf the Association in consequence of his conviction fQr an offence agai,nst

an Act of the ParLiament of Canada or Qf the LegLsla;ture of Alberta. (2, If a member of the ASlSQciation after due inquiry by the council Ls adjudged by them to have been guillty of infamous Qr unprofessional conduct in any respect or of p,rofessional incompetence, negligence Qr misoonduCit so gross as to disqualilfy ,sucll person in the opimon of the council from practilSing under this, Act, !the Ciouncil may give a written Oorder to the registrar of the Association ,to erase the name of such member from the register.

(3) A t'l"ue copy of the written order shaH be mailed to the member by fully prepaid re,gLstered pos,t addressed to h~m at his .last known 'address.

(4) When the council has so removed tl}e name Oof such peMOn from the re,gister the name of that person shall nOit again be entered thereupon exceipt under authority (

a) M a resolution of the council, or (

b) of an oo-der of a judge of the Supreme Court of Alberta.

(5) A pe'rson whose name has been directed to be erased from the register may ruppeaJ from the decisiOon M tl}e council to a jud,ge of the Supreme Court of Alberta at anytime wdthin six mQnths after the date Qf the order.

(6) Upon hearing the appeal the judge may make BlUch Oorder as to the restoration of the name SOl erased or confirming ,such erasure or for furUler inquiry by the councill iIllte the faC!ts of the case and as tOo the CiOSts as he considers just.

(7) The appeal may be by metion, nQtice Oof W1h1ch Siha;L1 be served upon the registra.r, and the registrar shall, upon requeB't Oof any person desiring to appeaJ,. furnh'!,h tOo him a certified OOIPY ef all pro ceedings, repQNS, orders and papers upon which the oouncll has acted ,in making tIle order complained of.

(8) No action lies agalinst the counciJl or its members for any pro ceedings taken O'r any judgments given or In fO'rce under the pro visions of this Act .... 3

(

I) provide that the annual fee of any member that remains unpaid for a period to be specified in such hy-Iaws be, on the expiration of such period, in creased to an amount specified in such by-laws, (

g) provide that the annual fees of non-resident or non-practising members be on a different basis from those of active members, (

h) provide that each active member be supplied with and keep prominently displayed in his place of business a certific'ate showing that he is a member of the Association, (

i) provide for the striking off the register and suspen sion from practice as a member of the Association any member for non-payment of fees due to the Association and for the reinstatement of such mem ber upon such terms as the council decides, and (

j) prescribe the qualifications of pharmaceutical in ternes and the terms and conditions of interneship.

(2) The council may establish, by by-law or by means of a code of ethics or otherwise, rules governing the con duct of members and internes of the As,sociation including advertising practices.

(3) Any by-laws may be amended, altered or repealed in whole or in part (

a) at any meeting of council, or (

b) at any annual general meeting of the Association if noUce is given of the intentipn to do so in accord- ance with the by-laws. -

(4) A by-law, rule or regulation does not come into effect until it has been ap'proved by the Lieutenant Governor in Council. 9.,

Section 21 is struck out and the following is sub stituted: Discipline 21.

(1) The council may, of its own motion, and may on the application of any person, inquire into and determine any matter of comp1aint against any member of the Associ ation where it is in substance alleged or the council has reasonable grounds for believing, that the member has been guilty of (

a) conduct detrimental to the public interest or of wilful negligence or of misconduct in the practice of his business or profession, or (

b) an offence or crime against

an Act of the Parlia ment of Canada or of the Legislature of Alberta relating to the sale of narcotic drugs, poisons or alcoholic liquors, or (

c) a contravention of this Act or any regulation made hereunder. 3

(2) Conduct detrim·ental to public interest or wilful negligence or mis·conduct, whether in a professional capacity or otherwise, within the meaning of this Act isa question of fact for the sole and final determination of the investi gating committee, or of the council on review, and any matter, conduct or thing that in the judgment of the investi gating committee or of the council on review is such as to be inimical to the best interests of the public or the pro fession is conduct detrimental to public interest within the meaning of this Act.

(3) The contravention of or the non-observance of any of the requirements of any by-law or code of ethics made under subsection (2) of

section 20 is conduct detrimental to the public interest. 21a.

(1) The council may appoint an investigating comlnittee consisting of not less than three members of council to hold an inquiry under

section 21.

(2) The registrar shall give at least ten d'ays' notice in writing of the intention to make the inquiry to the member whose conduct is being investigated and the notice shall (

a) specify in general terms the matter to be investi gated, (

b) specify the time and place at which the investiga tion will be held, and (

c) be served upon the member either personally or by being enclosed in a sealed prepaid registered envelope addressed and mailed to the member at his last post office address in the register of the Associ ation.

(3) A member whose conduct is being investigated may appear before the investigating committee in person or by counselor agent.

(4) Evidence may be adduced before an investigating committee either by affidavit or viva voce, or both, as the committee may determine and the chairman of the investi gating committee may administer oaths for the purposes of an investigation.

(5) The attendance of witnesses before an investigating committee and the production of drugs, books, prescriptions, prescription containers, papers and other documents m'ay be enforced by a notice issued under the hand of the regis trar and the seal of the Association, requiring the wit nesses to attend and stating the time and place at which the witness is to attend and the documents, if any, he is required to produce. 4

(6) A witness who (

a) fails to attend before an investigating committee in obedience to a notice to attend, or (

b) fails to produce any drugs, books, prescriptions,

prescription containers, papers or other documents in obedience to a notice to produce them, or (

c) who refuses to be sworn, or to answer any question allowed by an investigating committee, is liable to attachment upon application to a judge of the Supreme Court and may be punished as for contempt of court. 21b.

(1) The investigating committee (

a) shall report in writing to the council its findings and such recommendations as the committee or a majority thereof considers advisable, and (

b) shall forward the report with a copy of the evidence and a record of the proceedings before the com mittee to the registrar of the Association.

(2) The investigating committee may suspend the mem ber whose conduct is the subject of investigation until the next meeting of the council or for a period of three months, whichever period is the shorter. 21c.

(1) The council, at their next meeting after receipt of the report, shall consider the report and may (

a) declare the matter of complaint is or is not well founded, or (

b) order that the matter be referred ha'ck to the com mittee, or adjourned for consideration.

(2) Where the matter of complaint has been declared well founded, the council may (

a) order that the name of the member be erased from the register, (

b) order that the member be suspended from practising under this Act for such period as may be considered proper, or (

c) reprimand the member.

(3) In addition to or in lieu of an order or reprimand, the council may (

a) order that the member pay a sum of not less than fifty nor more than two hundred dollars to the funds of the Association within a time to be fixed by the order, and (

b) further order that in default of payment of any such sum so ordered to be paid within the time fixed for payment thereof, the member be suspended from practising until the sum has been paid.

(4) Where a member is suspended he ,shall not practise as a pharmaceutical chemist during the period of the suspension.

(5) Where the name of a person is erased from the register, the name of that person shall not again be entered thereupon except under authority of 5

10. (

a) The purpose of the amendment is to shorten the period of interneship to one year instead of two and to ensure that interneship is conducted in an approved pharmacy, i.e. one that will meet the requirements for interneship as prescribed by regulation. 6

(

a) a resolution of the council, or (

b) an order of a judge of the Supreme Court. 21d.

(1) A person (

a) whose name has been ordered to be erased from the register, or (

b) who has been suspended by order, may appeal to a judge of the Supreme Court in chambers at any time within thirty days after the date of the order.

(2) Where an appeal is made under this section, the operation of the order of the council is suspended until such time as the judge has finally pronounced thereon.

(3) The appeal may be by motion, notice of which shall be served upon the registrar within the time limited for appeal, and the registrar shall, upon request and at the cost of any person desiring to appeal, furnish to him a cer tified copy of all proceedings, reports, orders 'and papers upon which the council has acted in making the order com plained of.

(4) Upon hearing the appeal, the judge may make an order either confirming or reversing the order appealed from or directing a further inquiry by the council into the facts of the case, as he considers just. 21e. (1) 'The council or investigating committee may for the purpose of the execution of their duties under this Act, employ legal or other assistance and, if the matter of complaint has been declared well founded, may order that such costs together with any other costs of the inquiry, including witness fees, if any, shall be pa.id by the member whose conduct is being investigated.

(2) No action lies against the council or any committee thereof and the members of either or against an employee of the Association for any proceedings bona fide taken or enforced or attempted under any by-law or regulation of the Associa.tion. 21f.

(1) Any record required to be kept under this Act, under the Food and Drugs Act (Oanada) or under the Nar cotic Control Act (Oanada) shall be open to inspection by the registrar or by any inspector appointed under a by-law passed by the council.

(2) The registrar or an ins'pector appointed under a by-law passed by the council under this Act may enter any drug store in the performance of his duties under this Act at all reasonable times. 6

Section 25 is amended (

a) as to subsection (2) by striking out clause (

c) and by suhstituting the following: (

c) that he ha~ f?erved such period of pharma-

(

b) These subsections are no longer applicable as they were introduced to deal with certain conditions at the time, which no longer exist. II.

Section 27 presently reads: .. ~. A candidate shall be deemed to. have srutisfactory academdc qua:lifications if (

a) he satisfies the General Faculty Counoil of the Universtty o.f Alberta that his qualiflications at the time they were acquired were a.t lea'st the equivallent of those required fDr registration in the Province at that time, and 1;le produces a certificate from the registrar of the Undversdty 'SIO certifying, and (

b) he satisf.ies the C'OUIll(',U (il) that he graduated in pharmacy at least five years prior to. the date of his application fo.r regliiSitratiDn and tluLt he has been active in the practice Df pharmacy tl}roug'h. the majDr

part 0If the !,ive ye,ars immedia.tely preceding the date Df Ms application, Dr (iii) that he graduruted in pharmacy less than five years prior to the date of his appliicati'On fDr regils,tratio.n and that he ihas been in the active practice Df pl},armacy o.r eng'aged in post-graduate study thereof throughout the majDr part of the time between his graduation and his appliicatiDn for reg.istration." • 12. The purpose of the amendment is to place a maximum time limit upon interneship subject to the over-all discretion of the council in special cases. 7

ceutical interneship not to exceed twelve months .or as may be required by the council, in the actual practice of pharmacy in the dis pensary of a hospital or in a drug store approved by the c.ouncil of the Association. (

b) by striking out suhsection (3), (4) and (5).

Section 27 is amended by renumbering the

section as subsection (1) and by adding the following subsection:

(2) Before issuing a certificate of qualification the General Faculty Council of the University of Alberta may require an applicant for registration who do~s not qualify under clause (

b) of SUbsection (1) to take such examina tions as it considers necessary or to pursue further stUdies.

Section 30 is amended by adding the following sub sections:

(5) A pharmaceutical interne shall not continue as such if (

a) he fails to enrol in the course in pharmacy at the University of Alberta or other accredited univer sity within three years from the date of registration as a pharmaceutical interne, or ' (

b) he fa.ils to obtain the degree of Bachelor of Science in Pharmacy at the University of Alberta or other accredited university within seven years from the date of registration as a pharm'3!ceutical interne.

(6) Any person who fails to ,comply with this

section may apply to the council who may make such investigations of the circumstances as it may deem necessary and may (a,) order that the name of the pharmaceutical interne be erased from the register, or (

b) order that the pharmaceutical interne be permitted to remain as a pharmaceutical interne upon such conditions as may be considered proper.

(7) A person who ha.s failed to com/ply with subsection (5) shall not be permitted to remain 'as a pharmaceutical interne except under authority of a resolution of the council. 7

13. 31(1) (

a) and (b).

Section 31 (1) reworded -to refer directly to poisons, . drugs or medicines' specifically mentioned from time to time in Parts 1 and 2 of

Schedule I (now Schedules A and

B) which may be amended by the Lieutenant Governor in Council under

section 34. Subsection (2) has been struck Qut. Subsections (1) and (2) of

section 31 presently: read: . "31.

(1) Subject to subselctio.n (2), a peMOn who Is not registered unde.r this Aot and the holder of a valid and subsisting certif~cate of regi'stration sha1l not seH or keep open shop for.

U}.e retaildng, dispensing or compounding of podsions, drugs or medicine, except patent or proprietary m:,edicines as dellined by the Proprieta.ry o.r Pa:tentMedJicine Act (Canada), and except aspidn, tinoture of iodline two and one half per cent, creolin, carbolic acid solutILons not exceeding ten per cent, paris green, tUT'Pentine, ep·som salts" copperas, senna, borax, castor oil, .sulphur,. glauber's s·alt, cream of tJa.l'ltar, cal'lbonate of soda, blical'lbonate of S1Oda, g1Iycemne, cal"bona.te of ma.g nesla, citrate of magnesia, rochelle salts, .t:IaJ.tpetlre, spirlts of nitre, rhubaN rOOl1:, solution of ammonia, phoSIPiha.te 'of soda, gum camphor and chloride of lime, and except compounds for use in control o.f plant diseases and of pests and predators of plants and animals.

(2) Notwithstanding subsection (1), nothiing contained In Uti,s

section prevents any person sellling pOisons, drugs or medicine at any point in the Province more than fifteen miles from the neare.st place of business operated by a membe'!' of the Association, and all other proViisions of thi:s AClt in re·gard to the sale of poisons apply to any sale by any such pe.nmn .... (

c) Present

section 31(3) and (4) revised. See also note to the new

section 31 (2) following. (

d) Present

section 31(5) (a). (

e) and (

f) New. (

g) Present

section 31 (5) (

b) reworded. Subsection (5), clause (

b) presently reads: "

(5) No person (

b) shall display (1) any sIgn bearing the word,s· drugls, drug stlOre, drug dis" • pensary, drug sundries, or other words of like import, or (li) any f,~ture, title or advertisement implying or caloullilted to infe~ that he is regIstered under. this Act, ulNess sUch person haS taken out a cer.tLflcate under the p,rovlslons of this Act fot: .the U~e during which he is selling or keeping open shop .for retMh~g, dlsrpensmg or compounding poisons,' drugs or mediemes, or usmg such title .... , (2) ~ pharmaceutical interne is exempted from tQe provision o~ ~ectIon 3.1 (1) when acting under the immediate personal super VISIon and In the presence' of a pharmaceutical chemist.

The same provisions are presently contained in 31 (3) and (4). ,

(3) Present 3'1 (4a) . 8

_- '13.

Section 31 is struck out and the following is sub stituted: 31.

(1) Except 'as otherwise provided in this Act, no pers.on .other than a pharmaceutical chemist, shall (

a) keep open shop f.or retailing, compounding, dis pensing, supplying or distributing those P.oisons, drugs or medicines included in

Schedule A, or (

b) sell, offer for sale or keep for sale, by retail or distribute or supply any poison, drug or medicine included in

Schedule A, or (

c) dispens·e or compound prescriptions. of duly qualified medical practitioners, dentists, veterinary surgeons or podiatrists, or (

d) assum.e or use the title (

i) chemist and d'ruggist, (ii) chemist in connection with a retail business, (iii) druggist, (i

v) pharmacist, (

v) pharmaceutical chemist, (vi) apothecary, (vii) dispensing chemist, or (viii) dispensing druggist, or (

e) use the designation (

i) drug store, or (ii) pha.rmacy, or (iii) dispensary, or (/) use in connection with a retail or wholesale business, the designation (

i) drug sundries, or (ii) drug or drugs, or (iii) medicines, or (

g) use any sign or emblem, title or advertisement that implies or is calculated to lead the public to infer that he is registered as a pharmaceutical chemist.

(2) Clauses (

b) and (c) 'Of subsection (1) do not apply to a pharmaceutical interne when acting under the im mediate personal supervision and in the presence of a pharmaceutical chemist.

(3) Clause (

c) of subsection (1) does not apply to manufacturers of drugs under

section 36. 8

14. 3la. New. Subsection (1) would require drug stores to be operated by licensed pharmaceutical chemists only. Subsection (2) would require the name of the pharmaceutical chemist who is the proprietor of the pharmacy to be used after the name of the drug store in cases where a pharmacist carries on business under a name or style other than his own. 3lb. Any person who is carrying on the business of a drug store on April 30, 1964, but is not a licensed pharmaceutical chemist would be exempt from the provisions of

section 3la until April 30, 1974. 3lc. Clauses (

a) and (

b) are the present 31(6) reworded to make it apply to all drug stores and not just a branch, second or other shop. Subsection (6) of

section 31 presently reads: "

(6) No person Slhall ope,n or carry on any branch, second or other shop o,r place of business for reWling, dispensing or compounding any poisons. drugs or medicines, (

a) without f.irst paying the annual fee and otherwise complying wit!} the requirements of the Ass'oeiatiion in relation thereto. and (

b) withou.t placing and keeping such shop or place of business under the immediate per.sonal supervision and bona f'ide man a.gement of a pharmaceutical chemist duly regli&tered under this Act .... (

c) New. Provides that a licensed pharmaceutical chemist' must be present when the pharmacy is open for business. 31d. I;Tew. The

section would require every person who opens or acqUIres a drug store to supply full particulars regarding himself to the registrar. 3le. New. The purpose of this

section is to provide for a system of licensing for drug stores and prescribes the requirements for any such licence. 9

14. The following sections are added after

section 31 : 31a.

(1) Except as provided in subsection (2), every drug store shall be operated under the name of a bona fide proprietor thereof, and subject to sections 31band 31h no person shall be or become, or hold himself out as being, the proprietor of a drug store unless he is a pharmaceutical chemist.

(2) The proprietor of a drug store may use a business name or style other than his own name or a business name or style consisting of his own name with the addition of other words, if wherever such name or style is used it is followed by his own name and the word o'proprietor" or other word or words clearly indicating that he is the proprietor. 31b. Any person not being a corporation and not reg istered under this Act who was actually engaged in carry ing on the business of a drug store on the thirtieth day of April, 1964, may continue to carry on such business until the thirtieth day of April, 19 1 74, subject to his complying with

section 31c and all the other provisions of this Act. 31c. No person shall open or operate a drug store (

a) without first paying the annual fee and otherwise complying with the requirements of the Association in relation thereto, (

b) without placing and keeping such drug store under the immediate personal supervision and bona fide management of a pharmaceutical chemist, (

c) without a pharmaceutical chemist present on the premises at all times when the premises are open for business, and (

d) without notifying the registrar of the name of the manager thereof, and from time to time thereafter forthwith as such changes occur, notifying the registrar of any change in the management. Sid. Every person who opens or acquires a drug store shall at least thirty days before the date of the opening or the acquisition of the store, make and deliver to the registrar a declaration in writing over his signature, setting forth his full name, profession and residence, the date of the opening or acquisition of the store and the place where the store is situated. 31e.

(1) Every person who, and every corporation which, carries on the business of a pharmacy shall take out a pharmacy licence for the purpose.

(2) The applicant for a pharmacy licence shall (

a) file with the registrar an application in the form 9

31f. New. The

section would require a pharmaceutical chemist to obtain a pharmacy licence as well for any second or branch store operated by him. 31g. New. Self-explanatory. 10

prescribed by the cQuncil, giving such informatiQn as the cQuncil requires, (

b) furnish tQ the registrar satisfactQry evidence that the pharmacy is under the bona tide management and immediate persQnal supervisiQn 'Of the phar maceutical chemist, (

c) if SQ required, satisfy the cQuncil that he has ade quate and suitable stQck and dispensing equipment and an adequate and suitable pharmaceutical refer ence Hbrary and that with respect tQ general cleanli ness and sanitatiQn and 'Otherwise the premises, st'Ock and dispensing equipment are suitable fQr the compQunding, dispensing and sale 'Of drugs and medicines, and (

d) c'Omply with the by-laws 'Of the AssQciati'On respect- ing the issue 'Of a pharmacy licence, and thereuP'On and UPQn payment 'Of a licence fee n'Ot ex ceeding twenty-five dollars he shall be entitled tQ receive a pharmacy licence frQm the registrar.

(3) A pharmacy licence shall be in the fQrm prescribed by the cQuncil and shall 'entitle the hQlder thereQf tQ CQn duct or have cQnducted, in accQrdance with the prQvisiQns 'Of this Act, a drug stQre in the premises designated in the licence.

(4) The licenc'e shall be an annual licence, and shall be in f'Orce f'Or the term 'Of 'One year frQm a date fixed by the cQuncil.

(5) The licence, when issued, shall be displayed CQn tinuQusly ina cQnspicuQus place in the drug stQre in respect 'Of which it is issued.

(6) Every licence fQr a drug stQre owned by a c'Orpora ti'On shall be issued in the name 'Of a pharmaceutical 'chemist in charge thereof, whQ as well as the cQrpQratiQn shall be resP'Onsihle fQr the due compliance with the prQvisiQns 'Of this Act and liable fQr nQn-compliance therewith. 31t. NQ pharmaceutical chemist shall open 'Or carry 'On a branch 'Or 'Other shQP 'Or place 'Of business as a pharm aceutical chemist withQut first paying the annual fee and obtaining a pharmacy licence therefQr under this Act, bear ing UPQn its face 'the wQrds "branch licence"and withQut 'Otherwise cQmplying with

section 3le. 31g. Every pharmaceutical chemist, whether the 'Owner 'Or manager 'Of 'Or an empl'Oyee in a drug stQre 'Or pharmacy 'Or place 'Of business licensed under this Act, shall display and keep displayed in a c'Onspicuous public part there 'Of his licence f'Or the current year. 10

3lh. New. The provisions of this

section will require corpor ations to have a majority of its directors and shareholders licensed pharmaceutical chemists. Any corporation actually carrying on the business of a drug store on April 30, 1964, would be exempt from the provisions of subsection (2) until April 30, 1974. 3li.

(1) Present subsection (9) of

section 31 which reads: "

(9) A person who (

a) is registered under this Act. (

b) owns, opera;tes o.r is in charge of any dispensary, pharmacy, drug store or hospital dispensary, and (

c) ceases to own, operate or be in charge of such dispensary, pharmacy, drug store o'r 1}ospital dispensary, shall wi,thin f.ive days after such ces,sation notify the registrar of the Association in wrlit.ing of such ce.g.gation.".

(2) Present subsection (10) of

section 31 which reads: "

(10) A person who owns or IQperates a dispensary, pharmacy drug store or hospital dispensary that is in charge of a person reg{,stered under this Act shall Wli1Jhin five day;s after sud}. person has ceased to be in charge of the dispensary, piha,rma.cy, drug store lOr hospital dispensary not,lfy the registrar of the AS'sociation in wriltdng of the cessation." . 15. The purpose of the amendments to

section 34 is to provide for new Schedules A and B which have been added.

Section 34 presently reads: "34.

(1) The council may from time to time by resolution declare thElit any

article specifded in such res'OolutiOon is to be deemed a poison within the meaning of tl}f.s Act, and such resolution sha!,l specl'fy wihether such a-r1ltcle is to be included in

Part 1 or

Part 2 of

Schedule I.

(2) Upon passing such resolution the councdl shall submit it tOo the Lieutenant Governor in Council 1lor approval, and if approval i.s given to the resolution, such approval shaM be advelitised in The Alberta GazeHe, and on expiration oof one month after the date of the publi cation of suel} advertisement tJhe artiole named in the resolution shall be deemed to be included in

Part 1 or

Part 2, as the case may be, of

Schedule I.". 11

31h.

(1) No corporation shall operate a drug store un less the majority of the directors of the corporation are registered as pharmaceutical chemists under this Act.

(2) No corporation shall operate a drug store unless a majority of each class of shares of the corporation is owned by and registered in the name of pharmaceutical chemists.

(3) A corporation that was actually engaged in carrying on the business of a drug store on the thirtieth day of April, 1964, is exempt from the provisions of subsection (2) until the thirtieth day of April, 1974, but such corporation is subject to all the other provisions of this Act. 31i. A person who (

a) is registered under this Act, (

b) owns, operates or is in charge of any dispensary, pharmacy, drug store or hospital dispensary, and (

c) ceases to own, operate or be in charge of such dis pensary, pharmacy, drug store or hospital dis pensary, shall within five days after such cessation notify the reg istrar of the Association in writing of such cessation.

(2) A person who owns or operates a dispensary, pharm acy, drug store or hospital dispensary that is in charge of a person registered under this Act shall within five days after such person has ceased to be in charge of the dis pensary, pharmacy, drug store or hospital dispensary, notify the registrar of the Association in writing of such cessation.

Section 34 is struck out and the following is sub stituted: 34.

(1) Subject to the approval of the Lieutenant Gover nor in Council, the council by resolution may (

a) add any ·substance to, or (

b) remove any substance from, the list of substances in any part of Schedules A or Band may move a substance from one part of one

Schedule to another part of the same

Schedule or to a part of the other Schedule.

(2) The Regulations Act applies to a resolution under subsection (1), except that it does not come into effect until thirty days after the date of its publication in the Gazette. 11

16. Subsection (1) is the present 36 (1) reworded to eliminate reference to subsection (2) of present

section 36, which is no longer required because of amendments to

section 31 as well as to refer to new Schedules A and B. In addition, drug wholesalers and manufacturers would be required to have a pharmaceutical chemist present at all times when the premises are open for business. The present subsection (2) is omitted as it is no longer required because the specific articles mentioned have been elim inated under the new

section 31. The present subsection (3) be comes subsection (2) and is amended to refer to new Schedules A and B.

Section 36 presently reads: "36.

(1) Subject to subsectdon (2), a place in which d.rugs Oil" medicines are compounded Dr manufactured, Dr where manufacturers' Driginal paickagels are sUbdivided or broken up fDr the pUl"POose of repackaging into. either laT'ger Dr smaller quantit'ies, fDr sa.le either by retail or wholesale, Slhall be under the immediate supervision and b()na fide management of a duly quaLified and registered pharmaeeutica.l cheml'st under this Act.

(2) NO't:l}ing contained in this

section applies to those drugs named in subsection (1) .of sectJiDn 31, except paris green.

(3) All drugs and medicines, includ.ing thDs,e named in subsectiDn (1) of secmon 31, shall be properly labe,Lled by wholeswe dealers and retai,let1'!s before being .offered fDr saJe to the general public.". 17. (

a) The purpose of the amendment is to clarify the position of the seller in the case of restricted articles named in

Schedule A.

Section 37, subsection (1) presently reads: "37.

(1) No. pel'lson shall sell any .of the pO'iSIOns named in

Part 1 .of

Schedule I to any perso.n unknown to the seller unless intrDdu:ced tby SOome person known to. the seUer.". (

b) Reference should now be to the new

Schedule A. (c) Subsections (5) and (6) are new and intended to recog nize the new

Schedule B.

Section 39 presently reads: 12 "39. A perSDn contravening any .of the provhsions of this Act i,s guilty .of an .offence and is lia:ble on

summary oonvdoCtion for a finlt offence to' a f,i~e .of, not ,less than twenty-five dollars, and in default of payment to IrmJprISOnment for a term of not I~StS tlhan fifiteen days and fOor each subsequent .offence to a fine of no,t less than one hundl"ed do.llal'lS, and in default Df payment to impritSonment for a tenn ()If not less than siJm:y days.".

Section 36 is struck out and the following is sub stituted: 36.

(1) A place in which those drugs or medicines in cluded in

Schedule A or B are compounded or manufactured, or where manufacturers' original packages are subdivided or broken up for the purpose of repackaging into either larger or smaller quantities, for sale either by retail or wholesale, shall be under the immediate supervision and bona fide management of a pharmaceutical chemist and a pharmaceutical chemist shall be present on the premises at all times when the premises are open for business . .

(2) AIL drugs and medicines including those named in ,Schedules A or B, shall be properly labelled by wholesale dealers and retailers before being offered for sale -to the general pUblic.

Section 37 is amended (

a) by striking .out subsection (1) and by substituting the following: (b) (c) 37. ( 1) No person shall sell any of the poisons named in

Schedule A to any person unknown to the seller unless introduced by some pe'rson known to the seller or such person has provided the . 'seller with satisfactory proof of his identity and a satisfactory explanation for the purchase. as to subsection (3) by striking out the words "Schedule I" and by substituting the words "Schedule A", by adding the following subsections: ( 5) N.o pers.on shall sell, except t.o a duly qualified medical practiti.oner, a dentist, veterinary surgeon .or apodia trist or upon the prescr.iption of a medical practitioner, dentist, veterinary surgeon or podiat rist, any .of the articles or preparations thereof named or included in

Part 1 of

Schedule B. ('6) N.o person shall sell any of the articles named or included in

Part 2 of

Schedule B unless the box, vessel, bottle, wrapper or cover in which the

article is contained is distinctly labelled "For Agricultural Use Only".

Section 39 is struck out and the following is sub stituted: 39. A person who contravenes this Act is guilty of an offence and liable on

summary conviction, 12

19. New. The purpose of this

section is to place full re~ponsi bility for the operation of a drug store upon an owner, director or manager, as the case may be, and to make anyone of them liable for a contravention of the statute. 20. 42.

(1) The present subsection (1) revised. The purpose of the amendment is to place a limitation of 5 years upon the legal representative of a deceased pharmacist continuing to operate a drug store.

Section 42, subsection (1) presently reads: "42.

(1) Subject to subsection (2), upon the decease of any person IegaJly authorized to carry on the business of a phannaooutlcal chemi'st at the time of his death, the exeoutor. administrator or trtlJSltee of the estate of suoh person may contdnue the business. if any. so long as sucl} bus.iness is bona fide conducted by a phaT'lll&Ceutleail chemist registered under this Act .... ,

(2) New. The subsection provides for the insolvency, bank ruptcy-or assignment of a pharmaceutical chemist and authorizes his trustee to continue to operate the drug store for a period of one year unless otherwise intended by resolution of counci1.

(3) New. The subsection covers the situation where the majority shareholder of a corporation dies. The same privilege is extended to his estate as in the case of a death of an individual pharma ceutical chemist under the provisions of the new

section 41 (1). 13

(

a) for a first offence to a fine of not more than fifty dollars and in default of payment to imprisonment for a term of not more than thirty days, (

b) for a second offence to a fine of not more than five hundred dollars and in default of payment to im prisonment for a term of not more than sixty days, and (

c) for a third or subsequent offence to imprisonment for a term of not more than six months, without the option of a fine. 19. The following

section is added after

section 39: 39a.

(1) Where any person or corporation operates a drug store contrary to this Act or the by-laws enacted here under, the owner and directors or manager of the drug store, or anyone of them, may be proceeded against, and prosecution or conviction of anyone of them is not a bar to prosecution or conviction of the others, or any of them.

(2) Every owner, director or manager of a drug store is lia:ble for every offence against this Act or the by-laws en acted hereunder, committed by any person in his employ or under his supervision with his permission, consent or approval, express or implied.

Section 42 is struck out and the following is sub stituted: 42.

(1) Subject to subsection (4), upon the death of a person who was operating a drug store at the time of his death, the legal personal representative of the deceased person may continue to operate the drug store for a period of five years or for such longer period as the council may by resolution determine so long as such drug store is under the immediate personal supervision and bona fide management of a pharmaceutical chemist.

(2) Subject to subsection (4), where a person operating a drug store becomes bankrupt, insolvent, or makes an assignment for the general benefit of creditors, the trustee in bankruptcy, liquidator, or assignee,as the case may be, may operate the drug store for a period of one year or for such longer period as the council may by resolution de termine so long as such drug store is under the immediate ·personal supervision and bona fide management of a pharmaceutical·chemist.

(3) Subject to subsection (4), where by death the ma jority of the voting stock in a corporation operating a drug store ceases to be owned by and registered in the names of pharmaceutical chemists, the council may exempt the cor poration from the provisions of subsection (2) of

section 31h for a period of five years or for such longer period as the 13

(4) Present

section 42, subsection (2) reworded. That sub

section presently reads: "

(2) The executor, administrator or trustee ma"y carry on the busi ness only if he continues to pay the ann,uail registration fee a"s pro V'tded by the by-~'aw.s of tlhe Association.". 21. New. Self-explanatory. 22. The purpose of the amendment is to exempt permit holders under The Livestock Diseases Act from the provisions of The Alberta Pharmaceutical Association Act with the exception that any of the articles mentioned in

Part 2 of

Schedule B must be plainly labelled "For Agricultural Use Only". 14

council may Iby resolution determine so long as the drug store is under the immediate personal supervision and bona fide management of a pharmaceutical chemist.

(4) Any person entitled to operate a drug store under subsection (1), (2) or (3) may do so only if he continues to pay the annual registration fee as provided by ,the by-laws of the Association and complies with all other provisions of this Act. 21. The following

section is added after

section 42: 42a.

(1) All persons associated in partnership for the purpose of carrying on business as pharmaceutical chemists shall, within three months from the formation of the partnership cause to be filed with the registrar a -certificate signed by the members thereof stating (

a) the full name, occupation and residence of each partner, (

b) the name, style or firm under which the business is or is intended to be carried on, (

e) the time during which the partnership has existed, and (

d) that the persons therein named are the onlymem bers of the partnership.

(2) Every person engaged in business as a pharmaecutical chemist who is not associated in partnership with any other person but uses as his business style some name or designa tion other than his own name or uses his own name with the addition of the words "and company" or other words indicating a plurality of members shall, within three months from the time when such style is first used, cause to be filed with the registrar a certificate signed by him stating (

a) his full name, occupation and residence, (

b) the name, style or firm under which he carries on or intends to carryon business, and (

c) that no other person is associated with him in part nership.

Section 44 is amended by adding the following sub section:

(6) Nothing in this Act, except subsection (6) of

section 37, extends to or interferes with the selling of medicines for the diseases of livestock in accordance with the regula tions made by the Lieutenant Governor in Council under The Livestock Diseases Act. 14

23. Schedules amended. 24. C.ommencement of Act.

Schedule A The drugs or articles listed in

Schedule A, may be sold only to a medical practitioner, veterinary surgeon, or dentist, or on the prescription of a medical practioner, veterinary surgeon. or dentist; or by a podiatrist for those drugs authorized under The Podiatry Act. Certain of the drugs listed in this

Schedule may be sold by a pharmacist for livestock disease purposes when the orginal manu facturer's product is labelled "For Agricultural Use Only" .or "For Veterinary Use Only" when permitted by the Regulati.ons under the Food and Drugs Act (Canada). Those drugs preceded by "F" or "G" are also included in the corresponding schedules of the Food and Drugs Act (Canada) . The selected trade names in brackets are used for purposes of identification only. Drugs and products for agricultural use and registered under the federal Pest Contr.ol Products Act are exempted from the requirements of this Schedule. 15

23. The Schedules are amended (

a) by striking out

Schedule I and by sUbstituting Schedules A and B to this Act, (

b) by retitling

Schedule II as

Schedule C. 24. This Act comes into force on the first day of July, 1964.

SCHEDULE A (Sections 34, 36 and 37) F Aconiazide and its salts F Adrenocortical Hormones and their salts and derivatives (Cortef, Cortifan, CortiI, Meticorten, Hydeltra, Aristocort) F Aminoglutethimide (Elipten) F 4-Amino-N-Methylpteroyl Glutamic Acid and its salts (Methotrexa te ) F Aminopterin and its salts F 4-Amino-pteroyl Aspartic Acid and its salts ( Amino-An~Fol) F Aminopyrine and its derivatives (Pyramidon, Cibalgine, Optalidon) F Amitriptyline and its salts (ElaviI) G Amphetamine and its salts (Benzedrine, Benzolne, Dexedrine, Sulfate) Antibiotics, the following and their salts and de rivatives: F F F F F F F F F F (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (

I) Carbomycin (Magnamycin) Chloramphenicol (Chloromycetin, Enicol, Mycinol) Cycloserine (Seramycin) Dihydrostreptomycin (Gombistrep) Erythromycin (Erythrocin, Ilotycin) Griseofulvin (Grisovin, Fulvicin) Kanamycin (Kantrex) N eomycin--- (except in topical deodorants as authorized by the Food and Drug Directorate) Novobiocin (Albamycin, Cathomycin) Oleandomycin (Matromycin) Paromomycin (Humatin) Penicillin 15

F (

m) Polymyxin B (except for topical use or for local action in the oral cavity or nasal passages) (Aerosporin) F (

n) Spiramycin (Rovamycin) F ( 0) Streptomycin (IStrepolin) F (

p) Tetracycline (Achromycin, Tetracyn) F (

q) Viomycin (Viocin, Vinactane) F Anticoagulants, the following: (

a) Bishydroxycoumarin and its salts and de rivatives (Dufalone) (b) 4-Hydroxycoumarin and its derivatives when sold or recommended as anticoagul ants (ICumopyran, Tromexan, Warfarin, Panwarfin) (

c) Phenylindanedione and its derivatives (Danilone, Hedulin, Miradon) G Barbituric Acid and its salts and derivatives (Amy tal, Dial) F Bemegride (Megimide) G Benzphetamine and salts (Didrex) F Bretylium Tosylate (Darenthin) F Bromal and the following derivatives: (

a) Bromal Hydrate (

b) Brometone (

c) Bromoform F Busulfan (Myleran) FCalcium Carbimide (Temposil) F Carbromal and the following derivatives: (

a) Acetylcarbromal (Abasin, Anatensin) (

b) Allylisopropylacetylurea (ISedormid) (

c) Bromisoval (Bromural) (

d) Diethylbromacetamide (Ibatran) F Chloral and the following derivatives: (

a) Alpha-Chloralose (

b) Butyl Chloral Hydrate (

c) Chloralformamide (

d) Chloral Hydrate (except in preparations for external use containing not more than 1 %) (Noctec, Chloralol, Somnos, Nigra caps) (

e) Ohloralimide F Chlorambucil and its salts and derivatives (Leukeran) F Chlordiazepoxide and its salts (Librium) 16

F Chlorisondamine and its salts (Ecolid) F Chlormezanone (Trancopal) F Chloroquine and its salts (Aralen, MiIibis) F Ghlorprothixene and its salts (,Tarasan) F Cinchophen and its salts (Atophan) Oolchicumand derivatives Corticotrophin (A.!OTH) and preparations thereof (Acthar, Duractin) F Cyclizine (Marzine) Diaminodiphenylsulfone, and its analogues and deriva tives (Diasone, Promacetin, Avlosulfone) F Diazepam and -salts (Vallium) F Diethylpropion (Tenuate) F 2, 4-Dinitrophenol and its salts and derivatives (Obesolone) F Diphenylmethlane Derivatives, the following and their salts: (a) (b) (c) (d) (

e) Azacyclonol (Frenquel) Benactyzine (Suavitil) Captodiamine (Suvren) Hydroxyzine (Atarax) Piperliate (Sycotrol) F Disulfiram (Antabuse) F Ectylurea and its salts (Nostyn) F Emylcamate (Striatran) F Ergot Alkaloids and their salts (Gynergen, Ergotrate) F Ethchlorvynol (Placidyl) F Ethinamate (Valmid) F Ethionamide and its salts (Trecator) F Ethyl Trichloramate (Prodorm) Etryptamine and its salts (Monase) Fluorides for oral or topical use except in dentrifices F Fluorouracil and its derivatives G Glutethimide, its salts and derivatives (Doriden, Elipten) F Guanethidine and its salts (Ismelin) F Hexacyclonate Sodium Hexamethonium and its salts (Bistrium) F Hydantoin derivatives and their salts (except in pre parations for external use only) (Dilantin Sodium, Diphenate, Mesantoin) 17

F Hydralazine and its salts (ApresoIine) F Hydroxychloroquine and its salts (Plaquenil) Hyoscine (Scopolamine) and its salts; except in in halant preparations containing not more than 0.05 % by weight F Imipramine and its salts (,Tofranil) F Iproniazid and its salts (MarsiIid, Nydrazid, Rimifon, Niconyl) F Isocarboxazid and its salts (Marplan) F Isoniazid (Rimifon, Nidrazid) F Liothyronine (Cytomel, Tertroxin) Mecamylamine and its salts (Inversine) F Meclizine (Antivert, Bitas 707, 70.8, Bonadoxin, Bonadettes, Bonamine, Promesis) F Mephenoxalone (Trepidone) F Mephentermine and its salts (Wyamine) F Meprobamate (Equanil) F 6-Mercaptopurine (Purinethol) Mescal Buttons (Peyote Buttons) F Mescaline and its salts F Metaldehyde G Methamphetamine and its salts (Desoxyn, Syndros) F Methaqualone and its salts (Mequelon) Methimazole (Tapazole) Methonium (Hexameton) F Methopyrapone and its salts (Metopirone) F Methyldopa and its salts (Aldomet) F Methylparafynol (Dormison) F Methylphenidate and its salts (Ritalin) F Methyprylon (Noludar) F Methysergide and salts and derivatives (Sansert) Narcotine (Noscapine, Quadrin, Tuscopine) F Neocinchophen and its salts (Novatophan, Tolysin) F Nialamide and its salts (Niamid) Nystatin, its salts and derivatives, except in prepara tions for external use (Mycostatin) F Oil of Apioland preparations and compounds (Apergols) F Oxanamide (Quiactin) 18

F Oxyphenbutazone and its salts (Tandearil) Papaverine F Paraldehyde F Paramethadione (Paradione) F Pargyline and its salts (Eutonyl) F Pemoline and its salts (Cylert) F Pentolinium Tartrate (Ansolysen) F Phacetoperane and its salts (Lidepran) F Phenacimide (Phenuron) F Phenaglycodol F Phendimetrazine and its salts (Plegine) F Phenelzine and its salts (N'ardil) F Phenformin and its salts (DBl) F Pheniprazine and its salts (Catron) F Phenmetrazine and its salts (Preludin, Neo-Zinc, Neo Cozine, Probese-

P) F Phenothiazine Derivatives, the following and its salts: (

a) Acepromazine (ib) Chlorpromazine (

c) Fluphenazine (

d) Levomepromazine (

e) Mepazine (

f) Perphenazine (

g) Phenthoxate (

h) Prochlorperazine (

i) Promazine (

j) Thiopropazate (

k) Thioproperazine

(1) Thioridazine (

m) Trifluoperazine (

n) iTriflupromazine

(0) Trimeprazine F Phenylbutazone and its salts (Butazolidin) F Phenyltertiarybutylamine (Ionamin) Pipamazine (Mornidine) F Pipradrol and its salts (Mepatran, Sycotrol) F Primidone (Mysoline) F Prodilidine and its salts (Cogesic) F Prothipendyl Hydrochloride (Timoran) 19

Schedule B,

Part 1 The sale of drugs or articles in

Schedule B,

Part 1, is subject to the following restrictions: 1. To be sold only in drug stores. 2. To be sold only to persons known to the seller or introduced by some person known to the seller, or who has provided the seller with satisfactory proof of his identity and a satisfactory explanation for the purchase. 3. Sale must be registered in the "Poison Register" and the book must be signed by the purchaser. 4.

The package must be properly labelled with the name of the drug, the word "Poison" clearly and singly indicated in print, not less than one-half the size of type used in the name, and the name of the store where it is sold. 5. Drugs and products for agricultural use and registered under the federal Pest Control Products Act are exempted from the requirements of this Schedule. 20

F Pyrazinamide (Aldinamide) F Rauwolfia and the following Rauwolfia Alkaloids and their salts: (

a) Deserpidine (Ib) Raubasine (

c) Rescinnamine (

d) Reserpine F Sex Hormones (except cosmetic preparations contain ing sex hormones, which are demonstrated to be free from systemic effects) F Succinimide and its salts and derivatives (except those compounds used for decontaminating water) F Sulfinpyrazone and its salts (Anturan) F Sulfonamide·s and their salts and derivatives F Sulphonal and alkyl sulphonals (Sulfonal, Trioval) Thiocyanates (Scyan Elixir, Sulphocyalone) F Thiouracil and its derivatives F Thyroid (Proloid) F Thyroxin and its salts (Eltroxin, Synthroid) F Tolbutamide and its salts and derivatives F Tranylcypromine (Parnate) F Tretamine (TE:

M) F Triiodothyropropionic acid F Trimethadione (Trimedone) Urethane and any preparations containing urethane F Veratrum Album and its alkaloids and salts of alkaloids (Veralba) F Veratrum Viride and its alkaloids and salts of alkaloids (Unitensin, Vergitryl, Veriloid) SOHEDULE B

PART 1 (Sections 2, 34, 36, 37) Aconite and Alkaloids and preparations and compounds thereof Alkaloids; all poisonous vegetable alkaloids, not specifically mentioned elsewhere in these Schedules, and their salts and all poisonous derivatives thereof 20

Amyl Nitrite Atropine and any salt thereof Arsenic and preparations and compounds thereof, except Paris Green and except as provided in

Part 2 of this

Schedule Belladonna and alkaloids and preparations and compounds thereof, except plasters and except as provided in

Part 2 of this

Schedule Cantharides and preparations thereof Carbolic acid or preparations of a strength greater than 10% Chloroform (except in pharmaceutical preparations, Num ber 3 and 4 of

Schedule B,

Part 1 do not apply) Conium and Alkaloids and preparatiollB and compounds thereof Cotton Root, the Oil, derivatives and preparations Croton Oil Digitalis and Glycosides, and preparations and compounds thereof Emetine and salts thereof Ether Ethyl Chloride Hydrocyanic Acid (Prussic Acid) Hyoscyamus (except in pharmaceutical preparations, Num ber 3 and 4 of

Schedule B,

Part 1 do not apply) Lobelia and Alkaloids and preparations thereof (except in . pharmaceutical prepara tions, Number 3 and 4 of

Schedule B,

Part 1 do not apply) Mercurial Salts, except Calomel, and tablet form of Cor rosive Sublimate (Mercuric Chloride), when sold in confor'mity with the requirements of the Food and Drugs 'Act (Canada) Methyl Hydrate, (Wood Alcohol, Methanol, Wood Naptha) and any preparations thereof Nitroglycerin Nux Vomica and Alkaloids and preparations and compounds thereof Oil of Bitter Almonds, unless deprived of Hydrocyanic (Prussic) Acid Oil of Pennyroyal 21

Schedule B,

Part 2 The sale of drugs or articles in

Schedule B,

Part 2, is subject to the following conditions: 1. To be sold only in drug stores. 2. The package must be properly labelled with the name of the drug, the word "Poison" clearly and singly indicated in print, not less than one-half the size of type used in the name, and the name of the store where it is sold. 3. No "Poison Register" entry is required. 4. Drugs and products for agricultural use and registered under the federal Pest Control Products Act are exempted from the requirements of this Schedule. 22

Oil of Rue Oil of Savin Oil of Tansy Petassium Antimonyltartrate (Tartar Emetic) Potassium Cyanide and all other Metallic Cyanides includ ing Cyanogas except when under the control of The Setting of Poison Act, The Agricultural Pests Act or an official Pest Control Program of the Alberta De partment of Agriculture. Picrotoxin Santonin Strammonium and Alkaloids and preparations and com pounds thereof Strophanthus and Glycosides and preparations and com pounds thereof Strychnine and salts and preparations and compounds thereof, except as provided in

Part 2 of this

Schedule and when under the control of The Setting of Poison Act, The Agricultural Pests Act or' an official Pest Control Program of the Alberta Department of Agri culture Yohimba and Alkaloids and preparations and compounds thereof Acetanilid

PART 2 (Sections 2, 34, 36 and 37) Acetic Acid (ever 30 % ) Barium Chloride Barium ISulfide Benzene (Benzol) Carbolic Acid (Phenol) solutions of a strength of less than 10% Car:bon Disulfide Carbon 'Tetrachloride (provided that a cautionary label ac company it stating that it is a poison; that vapors from this solution are poisonous; that it should be used only in open air or well-ventilated rooms) Chromic Acid Copper Carbonate 22

Copper Subacetate (Verdigris) Cresol and its Homoloques, except Creolin Fluoride Salts, except for oral use, (See

Schedule

A) Guaiacol Hellebore Hydrochloric Acid Iodine and preparations thereof (except T'r.

Iodine 2¥2 % ) Iodoform Lead Salts and preparations thereof Mercury Mercury and Chalk Merbromin and preparations thereof (Mercurochrome), except solutions not greater than 2 % Mercurous Chloride Methyl Salicylate (when labelled "Caution: Keep out of the reach of Children") Nicotine and preparations and salts thereof (except in- secticidal preparations) Nitric Acid Oil of Chenopodium Oil of Wintergreen (when labelled "Caution: Keep out of the reach of Children") Oxalic Acid Phosphorous in free state Picric Acid (Trinitrophenol) Podophyllin Potassium Bichromate Potassium Hydroxide Potassium Nitrite Potassium Permanganate Silver Nitrate Selenium, and any salts and preparations thereof except for agricultural use and when registered under the federal Feeds Act Sodium Hydroxide Sodium Nitrite 23

Stavesacre (Larkspur, Delphinium) Sulfuric Acid Trichloroethylene (when labelled as such and where the lathel bears the skull and cross~bones insignia and the following wording : ~'Poison - Vapours and odours from this solution are poisonous. Use only in open air or well-ventilated room"; and where the name of the pharmacy in which such sale is made is displayed on the container) Thallium Salts Tobacco Extract (except in insecticidal preparations) Zinc Salts, except for agricultural use and registered under the federal Feeds Act. 24

No. 111 FIRST SESSION FIFTEENTH LEGISLATURE 12 ELIZABETH II 1964 BILL

An Act to amend The Alberta Pharmaceutical Association Act Received and read the First time Second time Third time RON. DR. Ross Title: 1964 (15th, 1st) Bill 111,

An Act to amend The Alberta Pharmaceutical Association Act

Document details

Collection	Alberta — Bills
Citation	L15 S1 1690
Type	bill
Volume / chapter	L15 S1 1690
Language	en
Format	json
Source	PROVINCIAL
Identifier	8560a6b617743724af8f6c80c672f093ab304316

Source file is stored in the law ingest library (json).